Publications
Journals
- Atkin SJL; Griffin BE; Dilworth SM. (Aug 2009). Polyoma virus and simian virus 40 as cancer models: History and perspectives. SEMIN CANCER BIOL. 19:211-217. DOI.
- Phillips JA; Griffin BE. (Dec 2007). Pilot study of sodium phenylbutyrate as adjuvant in cyclophosphamide-resistant endemic Burkitt's lymphoma. T ROY SOC TROP MED H. 101:1265-1269. DOI.
- Syed N; Smith P; Sullivan A; Spender LC; Dyer M; Karran L; O'Nions J; Allday M; et alHoffmann I; Crawford D; Griffin B; Farrell PJ; Crook T. (1 Jan 2006). Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood. 107:250-256. DOI.
- Xue SA; Griffin BE. (2007). Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication. Nucleic Acids Res. 35:3391-3406. DOI.
- Wang YH; Xue SA; Hallden G; Francis J; Yuan M; Griffin BE; Lemoine NR. (15 Feb 2005). Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors. CANCER RES. 65:1523-1531.
- Caparrós-Wanderley W; Clark B; Griffin BE. (2 Jan 2004). Effect of dose and long-term storage on the immunogenicity of murine polyomavirus VP1 virus-like particles. Vaccine. 22:352-361.
- Xue SA; Lampert IA; Haldane JS; Bridger JE; Griffin BE. (7 Jul 2003). Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger?. Br J Cancer. 89:113-119. DOI.
- Xue SA; Jones MD; Lu QL; Middeldorp JM; Griffin BE. (Mar 2003). Genetic diversity: frameshift mechanisms alter coding of a gene (Epstein-Barr virus LF3 gene) that contains multiple 102-base-pair direct sequence repeats. Mol Cell Biol. 23:2192-2201.
- Kazembe P; Hesseling PB; Griffin BE; Lampert I; Wessels G. (Jan 2003). Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. MED PEDIATR ONCOL. 40:23-25. DOI.
- Mannová P; Liebl D; Krauzewicz N; Fejtová A; Stokrová J; Palková Z; Griffin BE; Forstová J. (Sep 2002). Analysis of mouse polyomavirus mutants with lesions in the minor capsid proteins. J Gen Virol. 83:2309-2319.
- Xue SA; Labrecque LG; Lu QL; Ong SK; Lampert IA; Kazembe P; Molyneux E; Broadhead RL; et alBorgstein E; Griffin BE. (10 Jun 2002). Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi. Int J Cancer. 99:635-643. DOI.
- Heidari S; Vlastos A; Ramqvist T; Clark B; Griffin BE; Garcia MI; Perez M; Amati P; et alDalianis T. (22 Feb 2002). Immunization of T-cell deficient mice against polyomavirus infection using viral pseudocapsids or temperature sensitive mutants. Vaccine. 20:1571-1578.
- Gao Y; Lu YJ; Xue SA; Chen H; Wedderburn N; Griffin BE. (24 Jan 2002). Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus. Oncogene. 21:825-835. DOI.
- Clark B; Caparrós-Wanderley W; Musselwhite G; Kotecha M; Griffin BE. (Nov 2001). Immunity against both polyomavirus VP1 and a transgene product induced following intranasal delivery of VP1 pseudocapsid-DNA complexes. J Gen Virol. 82:2791-2797.
- Ong SK; Xue SA; Molyneux E; Broadhead RL; Borgstein E; Ng MH; Griffin BE. (Jan 2001). African Burkitt's lymphoma: a new perspective. Trans R Soc Trop Med Hyg. 95:93-96.
- Heidari S; Krauzewicz N; Kalantari M; Vlastos A; Griffin BE; Dalianis T. (Dec 2000). Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus. J VIROL. 74:11963-11965.
- Krauzewicz N; Stokrová J; Jenkins C; Elliott M; Higgins CF; Griffin BE. (Dec 2000). Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids. Gene Ther. 7:2122-2131. DOI.
- Krauzewicz N; Cox C; Soeda E; Clark B; Rayner S; Griffin BE. (Jul 2000). Sustained ex vivo and in vivo transfer of a reporter gene using polyoma virus pseudocapsids. Gene Ther. 7:1094-1102. DOI.
- Griffin BE. (Apr 2000). Epstein-Barr virus (EBV) and human disease: facts, opinions and problems. Mutat Res. 462:395-405.
- Smith PR; de Jesus O; Turner D; Hollyoake M; Karstegl CE; Griffin BE; Karran L; Wang Y; et alHayward SD; Farrell PJ. (Apr 2000). Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol. 74:3082-3092.
- Xue SA; Lu QL; Poulsom R; Karran L; Jones MD; Griffin BE. (Mar 2000). Expression of two related viral early genes in Epstein-Barr virus-associated tumors. J Virol. 74:2793-2803.
- Krauzewicz N; Griffin BE. (2000). Polyoma and papilloma virus vectors for cancer gene therapy. Adv Exp Med Biol. 465:73-82. DOI.
- Gao Y; Xue S; Griffin BE. (Nov 1999). Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript. Mol Cell Biol. 19:7305-7313.
- Labrecque LG; Xue SA; Kazembe P; Phillips J; Lampert I; Wedderburn N; Griffin BE. (31 Mar 1999). Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation with patient response to therapy. Int J Cancer. 81:6-11.
- Stokrova J; Palkova Z; Fischer L; Richterova Z; Korb J; Griffin BE; Forstova J. (19 Feb 1999). Interactions of heterologous DNA with polyomavirus major structural protein, VPI. FEBS LETT. 445:119-125.
- Elliott J; Jones MD; Griffin BE; Krauzewicz N. (8 Oct 1998). Regulation of cytoskeletal association by a basic amino acid motif in polyoma virus middle T antigen. Oncogene. 17:1797-1806. DOI.
- Soeda E; Krauzewicz N; Cox C; Stokrová J; Forstová J; Griffin BE. (Oct 1998). Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids. Gene Ther. 5:1410-1419. DOI.
- Cox C; Naylor BA; Mackett M; Arrand JR; Griffin BE; Wedderburn N. (Aug 1998). Immunization of common marmosets with Epstein-Barr virus (EBV) envelope glycoprotein gp340: Effect on viral shedding following EBV challenge. J MED VIROL. 55:255-261.
- Griffin BE; Xue SA. (Jun 1998). Epstein-Barr virus infections and their association with human malignancies: some key questions. Ann Med. 30:249-259.
- Griffin BE. (Apr 1998). Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis - Introduction. REV MED VIROL. 8:61-+.
- Griffin BE. (Apr 1998). Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Rev Med Virol. 8:61-66.
- Labrecque LG; Barnes DM; Fentiman IS; Griffin BE. (1 Jan 1995). Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 55:39-45.
- Labrecque LG; Lampert I; Kazembe P; Philips J; Griffin BE. (1 Dec 1994). Correlation between cytopathological results and in situ hybridisation on needle aspiration biopsies of suspected African Burkitt's lymphomas. Int J Cancer. 59:591-596.
- GRIFFIN BE. (3 Mar 1994). EMERGING VIRUSES. - MORSE,SS. NATURE. 368:25-26.
- van den Bosch C; Griffin BE; Kazembe P; Dziweni C; Kadzamira L. (Dec 1993). Are plant factors a missing link in the evolution of endemic Burkitt's lymphoma?. Br J Cancer. 68:1232-1235.
- Streuli CH; Krauzewicz NS; Griffin BE. (Aug 1990). Recombination resulting in unusual features in the polyomavirus genome isolated from a murine tumor cell line. J Virol. 64:3570-3580.
- Karran L; Teo CG; King D; Hitt MM; Gao YN; Wedderburn N; Griffin BE. (15 Apr 1990). Establishment of immortalized primate epithelial cells with sub-genomic EBV DNA. Int J Cancer. 45:763-772.
- GRIFFIN BE. (20 Apr 1989). AIDS - THE HIV MYTH - ADAMS,J. NATURE. 338:670-670.
- Venables PJ; Teo CG; Baboonian C; Griffin BE; Hughes RA. (Mar 1989). Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome. Clin Exp Immunol. 75:359-364.
- STRAUSS M; LUBBE L; KIESSLING U; PLATZER M; GRIFFIN BE. (1989). THE MUTAGENIC AND IMMORTALIZING POTENTIAL OF POLYOMA-VIRUS LARGE T-ANTIGEN. CURR TOP MICROBIOL. 144:129-134.
- Kinchington D; Griffin BE. (23 Dec 1987). Size heterogeneity of EBV and mitochondrial DNAs in Burkitt's lymphoma lines. Nucleic Acids Res. 15:10345-10354.
- Street AJ; Griffin BE. (Dec 1987). Immunological variation in the 'common region' of the T antigens of polyoma virus. J Gen Virol. 68 ( Pt 12):3153-3164.
- STREET AJ; GRIFFIN BE. (Dec 1987). IMMUNOLOGICAL VARIATION IN THE COMMON REGION OF THE T-ANTIGENS OF POLYOMA-VIRUS. J GEN VIROL. 68:3153-3164.
- DOWNING RG; SEWANKAMBO N; SERWADDA D; HONESS R; CRAWFORD D; JARRETT R; GRIFFIN BE. (15 Aug 1987). ISOLATION OF HUMAN LYMPHOTROPIC HERPESVIRUSES FROM UGANDA. LANCET. 2:390-390.
- GRIFFIN BE. (9 Jul 1987). DNA TUMOR-VIRUSES - CONTROL OF GENE-EXPRESSION AND REPLICATION - BOTCHAN,M, GRODZICKER,T, SHARP,PA. NATURE. 328:120-121.
- STREULI CH; GRIFFIN BE. (9 Apr 1987). MYRISTIC ACID IS COUPLED TO A STRUCTURAL PROTEIN OF POLYOMA-VIRUS AND SV40. NATURE. 326:619-622.
- HARRIS A; YOUNG BD; GRIFFIN BE. (1985). RANDOM ASSOCIATION OF EPSTEIN-BARR VIRUS GENOMES WITH HOST-CELL METAPHASE CHROMOSOMES IN BURKITTS LYMPHOMA-DERIVED CELL-LINES. J VIROL. 56:328-332.
- DILWORTH SM; COWIE A; KAMEN RI; GRIFFIN BE. (1984). DNA-BINDING ACTIVITY OF POLYOMA-VIRUS LARGE TUMOR-ANTIGEN. P NATL ACAD SCI-BIOL. 81:1941-1945.
- GRIFFIN BE; KARRAN L. (1984). IMMORTALIZATION OF MONKEY EPITHELIAL-CELLS BY SPECIFIC FRAGMENTS OF EPSTEIN-BARR VIRUS-DNA. NATURE. 309:78-82.
- JONES MD; FOSTER L; SHEEDY T; GRIFFIN BE. (1984). THE EB VIRUS GENOME IN DAUDI BURKITTS-LYMPHOMA CELLS HAS A DELETION SIMILAR TO THAT OBSERVED IN A NON-TRANSFORMING STRAIN (P3HR-1) OF THE VIRUS. EMBO J. 3:813-821.
- MCCANCE DJ; SEBESTENY A; GRIFFIN BE; BALKWILL F; TILLY R; GREGSON NA. (1983). A PARALYTIC DISEASE IN NUDE-MICE ASSOCIATED WITH POLYOMA-VIRUS INFECTION. J GEN VIROL. 64:57-67.
- JONES MD; GRIFFIN BE. (1983). CLUSTERED REPEAT SEQUENCES IN THE GENOME OF EPSTEIN-BARR VIRUS. NUCLEIC ACIDS RES. 11:3919-3937.
- GRIFFIN BE; DILWORTH SM. (1983). POLYOMAVIRUS - AN OVERVIEW OF ITS UNIQUE PROPERTIES. ADV CANCER RES. 39:183-268.
- DILWORTH SM; GRIFFIN BE. (1983). THE TRANSFORMING GENE OF POLYOMA-VIRUS. ARCH GESCHWULSTFORSC. 53:187-195.
- DING D; DILWORTH SM; GRIFFIN BE. (1982). MLT MUTANTS OF POLYOMA-VIRUS. J VIROL. 44:1080-1083.
- DILWORTH SM; GRIFFIN BE. (1982). MONOCLONAL-ANTIBODIES AGAINST POLYOMA-VIRUS TUMOR-ANTIGENS. P NATL ACAD SCI-BIOL. 79:1059-1063.
- DING DM; JONES MD; LEIGHBROWN A; GRIFFIN BE. (1982). MUTANT DIN-21, A VARIANT OF POLYOMA-VIRUS CONTAINING A MOUSE DNA-SEQUENCE IN THE VIRAL GENOME. EMBO J. 1:461-466.
- SMOLAR N; GRIFFIN BE. (1981). DNA-SEQUENCES OF POLYOMA-VIRUS EARLY DELETION MUTANTS. J VIROL. 38:958-967.
- ARRAND JR; RYMO L; WALSH JE; BJORCK E; LINDAHL T; GRIFFIN BE. (1981). MOLECULAR-CLONING OF THE COMPLETE EPSTEIN-BARR VIRUS GENOME AS A SET OF OVERLAPPING RESTRICTION ENDONUCLEASE FRAGMENTS. NUCLEIC ACIDS RES. 9:2999-3014.
- NOVAK U; GRIFFIN BE. (1981). REQUIREMENT FOR THE C-TERMINAL REGION OF MIDDLE T-ANTIGEN IN CELLULAR-TRANSFORMATION BY POLYOMA-VIRUS. NUCLEIC ACIDS RES. 9:2055-2073.
- GRIFFIN BE; NOVAK U. (1980). CELLULAR-TRANSFORMATION BY POLYOMA-VIRUS. EUR J CELL BIOL. 22:525-525.
- NOVAK U; DILWORTH SM; GRIFFIN BE. (1980). CODING CAPACITY OF A 35-PERCENT FRAGMENT OF THE POLYOMA-VIRUS GENOME IS SUFFICIENT TO INITIATE AND MAINTAIN CELLULAR-TRANSFORMATION. P NATL ACAD SCI-BIOL. 77:3278-3282.
- SOEDA E; ARRAND JR; SMOLAR N; WALSH JE; GRIFFIN BE. (1980). CODING POTENTIAL AND REGULATORY SIGNALS OF THE POLYOMA-VIRUS GENOME. NATURE. 283:445-453.
- SOEDA E; MARUYAMA T; ARRAND JR; GRIFFIN BE. (1980). HOST-DEPENDENT EVOLUTION OF 3 PAPOVA VIRUSES. NATURE. 285:165-167.
- ITO Y; SPURR N; GRIFFIN BE. (1980). MIDDLE-T ANTIGEN AS PRIMARY INDUCER OF FULL EXPRESSION OF THE PHENOTYPE OF TRANSFORMATION BY POLYOMA-VIRUS. J VIROL. 35:219-232.
- GRIFFIN BE; DILWORTH SM; ITO Y; NOVAK U. (1980). POLYOMA-VIRUS - SOME CONSIDERATIONS ON ITS TRANSFORMING GENES. P ROY SOC LOND B BIO. 210:465-476.
- SOEDA E; ARRAND JR; GRIFFIN BE. (1980). POLYOMA-VIRUS DNA - COMPLETE NUCLEOTIDE-SEQUENCE OF THE GENE WHICH CODES FOR POLYOMA-VIRUS CAPSID PROTEIN VP1 AND OVERLAPS THE VP2-VP3 GENES. J VIROL. 33:619-630.
- ARRAND JR; SOEDA E; WALSH JE; SMOLAR N; GRIFFIN BE. (1980). POLYOMA-VIRUS DNA - SEQUENCE FROM THE LATE REGION THAT SPECIFIES THE LEADER SEQUENCE FOR LATE MESSENGER-RNA AND CODES FOR VP2, VP3, AND THE N-TERMINUS OF VP1. J VIROL. 33:606-618.
- GRIFFIN BE; ITO Y; NOVAK U; SPURR N; DILWORTH S; SMOLAR N; POLLACK R; SMITH K; et alRIFKIN DB. (1979). EARLY MUTANTS OF POLYOMA-VIRUS (DL8 AND DL23) WITH ALTERED TRANSFORMATION PROPERTIES - IS POLYOMA-VIRUS MIDDLE T-ANTIGEN A TRANSFORMING GENE-PRODUCT. COLD SPRING HARB SYM. 44:271-283.
- GRIFFIN BE; MADDOCK C. (1979). NEW CLASSES OF VIABLE DELETION MUTANTS IN THE EARLY REGION OF POLYOMA-VIRUS. J VIROL. 31:645-656.
- SOEDA E; ARRAND JR; GRIFFIN BE. (1979). POLYOMA-VIRUS - EARLY REGION AND ITS T-ANTIGENS. NUCLEIC ACIDS RES. 7:839-857.
- SOEDA E; ARRAND JR; SMOLAR N; GRIFFIN BE. (1979). SEQUENCE FROM EARLY REGION OF POLYOMA-VIRUS DNA CONTAINING VIRAL REPLICATION ORIGIN AND ENCODING SMALL, MIDDLE AND (PART OF) LARGE T-ANTIGENS. CELL. 17:357-370.
- SOEDA E; GRIFFIN BE. (1978). SEQUENCES FROM GENOME OF A NON-TRANSFORMING MUTANT OF POLYOMA-VIRUS. NATURE. 276:294-298.
- GRIFFIN BE. (1977). FINE-STRUCTURE OF POLYOMA-VIRUS DNA. J MOL BIOL. 117:447-471.
- LUND E; FRIED M; GRIFFIN BE. (1977). POLYOMA-VIRUS DEFECTIVE DNAS .1. PHYSICAL MAPS OF A RELATED SET OF DEFECTIVE MOLECULES (D76, D91, D92). J MOL BIOL. 117:473-495.
- LUND E; GRIFFIN BE; FRIED M. (1977). POLYOMA-VIRUS DEFECTIVE DNAS .2. PHYSICAL MAP OF A MOLECULE WITH REARRANGED AND REITERATED SEQUENCES (D74). J MOL BIOL. 117:497-513.
- GRIFFIN BE. (1976). MAPPING OF GENOMES OF POLYOMA AND SV40 VIRUSES. HEREDITY. 36:287-287.
- GRIFFIN BE; FRIED M. (1975). AMPLIFICATION OF A SPECIFIC REGION OF POLYOMA-VIRUS GENOME. NATURE. 256:175-179.
- GRIFFIN BE; FRIED M; COWIE A. (1974). POLYOMA DNA - PHYSICAL MAP. P NATL ACAD SCI USA. 71:2077-2081.
- FRIED M; GRIFFIN BE; LUND E; ROBBERSON DL. (1974). POLYOMA-VIRUS - STUDY OF WILD-TYPE, MUTANT AND DEFECTIVE DNAS. COLD SPRING HARB SYM. 39:45-52.
Chapters in books
- Griffin BE; Rochford R. Endemic Burkitt's Lymphoma. In Epstein-Barr Virus. 113-137. Robertson ES (ed). Caister Academic Press, UK (2006).
- Griffin BE; Caparros-Wanderley W. Human DNA tumour viruses. In The cancer handbook. 49-73. (2002).
Conferences
- Wang YH; Xue SA; Hallden G; Francis J; Griffin BE; Lemoine NR. VAI deleted adenovirus as an oncolytic agent targeting human EBV-associated tumours. 9:S230-S230. (May 2004).
- Wang YH; Francis J; Griffin BE; Lemoine NLR; Xue SA. Cytotoxicity of replication-competent adenovirus to lymphoproliferative disorders correlates with expression of heparan sulfate. 7:S359-S359. (May 2003).


